Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation [Clinical Sciences]

Conclusions— In majority of patients who receive antithrombotic agents, treatment is initiated within 6 months of ICH. Still, many patients with compelling indications for antithrombotic treatment are not prescribed antithrombotic agents. Factors other than high risk of embolic stroke by CHA2DS2-VASc in ICH survivors with concurrent AF are used to guide the anticoagulant treatment decision in Swedish clinical practice.

http://stroke.ahajournals.org/cgi/content/short/46/8/2094?rss=1

Source: Stroke - July 27, 2015 Category: Neurology Authors: Pennlert, J., Asplund, K., Carlberg, B., Wiklund, P.-G., Wisten, A., Asberg, S., Eriksson, M. Tags: Acute Cerebral Hemorrhage, Anticoagulants, Antiplatelets, Epidemiology Clinical Sciences Source Type: research